Showing 8511-8520 of 18133 results for "".
- Long COVID: Impact on Child Mental Healthhttps://reachmd.com/news/long-covid-impact-on-child-mental-health/2474782/Emerging evidence confirms that nearly 40% of children with Long COVID experience significant symptoms of anxiety or depression. These findings, supported by validated psychological screening tools, reinforce the urgent need to integrate mental health assessments i
- Revolutionizing Cancer Detection: Innovations in Imaging Technologieshttps://reachmd.com/news/revolutionizing-cancer-detection-innovations-in-imaging-technologies/2474746/In the evolving landscape of cancer detection, new imaging technologies are reshaping how radiologists approach diagnosis and treatment, particularly through advanced developments in positron emission tomography (PET) and magnetic resonance i
- Post-COVID-19 Lung Disease: Evaluating Biochemical and Imaging Markershttps://reachmd.com/news/post-covid-19-lung-disease-evaluating-biochemical-and-imaging-markers/2474677/As the global community navigates the aftermath of COVID-19, experts in Pulmonary Medicine and Infectious Disease are increasingly focused on detecting and managing residual lung inflammation. Compelling evidence demonstrates that biochemical markers—such as LDH, I
- Gut Microbiome: Implications for Vascular Inflammation and Kawasaki Diseasehttps://reachmd.com/news/gut-microbiome-implications-for-vascular-inflammation-and-kawasaki-disease/2474113/Groundbreaking preclinical mouse studies have clarified the pivotal influence of the gut microbiome in controlling vascular inflammation. Experiments demonstrated that decreasing the gut microbial population in mice led to a substantial reduction i
- Understanding Health-Related Quality of Life Beyond Injury: An Integrated Approachhttps://reachmd.com/news/understanding-health-related-quality-of-life-beyond-injury-an-integrated-approach/2471183/Healthcare professionals increasingly recognize the importance of evaluating health-related quality of life (HRQL) in patients post-injury. Both systematic reviews and recent studies highlight the nuances of patient experiences, including gender-specific differences, that i
- Examining the Influence of Volunteering on Depression in Older Adultshttps://reachmd.com/news/examining-the-influence-of-volunteering-on-depression-in-older-adults/2470962/What's New A recent study by Columbia University highlights how engaging in volunteer activities can reduce depression rates in older adults. Significance The research identifies a significant correlation between volunteering and reduced depression i
- Differentiating Clinical Presentations in Interstitial Cystitis and Bladder Pain Syndromehttps://reachmd.com/news/differentiating-clinical-presentations-interstitial-cystitis-and-bladder-pain-syndrome/2470888/What's New A study finds significant differences between interstitial cystitis (IC) and bladder pain syndrome (BPS), which may guide specialized treatment approaches. Significance The differentiation is crucial for developing targeted therapies and i
- Study Finds Food Insecurity Increases Hospital Stays and Odds of Readmissionhttps://reachmd.com/news/study-finds-food-insecurity-increases-hospital-stays-and-odds-of-readmission/2468206/BYLINE: Myra Wright Newswise — WINSTON-SALEM, N.C. – Sept. 16, 2024 – Food insecurity, which is the limited or uncertain availability of nutritionally adequate and safe food, is associated with poor health outcomes and the i
- Tattoo Removal Trends Revealed in Global Analysis of Over 200,000 Individualshttps://reachmd.com/news/tattoo-removal-trends-revealed-in-global-analysis-of-over-200000-individuals/2475357/Key Takeaways Individuals aged 18–39 make up two-thirds of those seeking tattoo removal, with visible areas such as forearms and hands being the most treated. Black ink remains the most commonly removed tattoo pigment. Fitzpatrick Skin Types III and
- Blood Biomarkers Illuminate Early Risk in Systemic Sclerosishttps://reachmd.com/news/blood-biomarker-and-risk-assessment-in-systemic-sclerosis/2474136/For patients with systemic sclerosis (SSc), early identification of severe disease progression can be the difference between stabilizing organ function and managing irreversible damage. New research highlights how blood-based biomarkers—particularly type 1 interfer